Editas Medicine Inc Asset Turnover Ratio (EDIT), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Editas Medicine Inc   (NASDAQ: EDIT)
 

Editas Medicine Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Editas Medicine Inc asset turnover ratio, the ability of Editas Medicine Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.21 in the first quarter (Mar 31 2026), a new company high.

Within sector 34 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 1292 to 2763.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EDIT Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -43.36 % -45.39 % -38.41 % -45.26 % -40.27 %
Y / Y Revenue Change -39.22 % -19.16 % 12265.57 % 597.47 % 310.4 %
Asset Turnover Ratio (TTM) 0.21 0.19 0.18 0.14 0.11
EDIT's Total Ranking # 2763 # 1292 # 0 # 2863 # 1095
Seq. Asset Change -19.94 % -7.54 % -4.19 % -20.13 % -22.82 %
Seq. Revenue Change -88.56 % 228 % 110.82 % -23.19 % -84.78 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 35
Healthcare Sector # 415
Overall Market # 2763

Asset Turnover Ratio Statistics
High Average Low
0.21 0.09 0.03
(Mar 31 2026)   (Sep 30 2021)




EDIT Company Profile • Back to EDIT Efficiency Comparisons • Compare EDIT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Mirum Pharmaceuticals Inc   0.70 $ 569.609  Millions$ 811.167  Millions
Neurocrine Biosciences Inc   0.70 $ 3,102.400  Millions$ 4,423.300  Millions
Harrow Inc   0.70 $ 267.575  Millions$ 381.783  Millions
Quest Diagnostics Inc  0.69 $ 11,278.000  Millions$ 16,266.000  Millions
Dexcom Inc   0.69 $ 4,817.200  Millions$ 6,950.050  Millions
Lifestance Health Group Inc   0.69 $ 1,494.791  Millions$ 2,161.397  Millions
Illumina Inc   0.69 $ 4,393.000  Millions$ 6,366.750  Millions
Lantheus Holdings Inc   0.69 $ 1,545.174  Millions$ 2,241.616  Millions
Inotiv Inc   0.68 $ 507.356  Millions$ 741.901  Millions
Jaguar Health Inc   0.68 $ 29.569  Millions$ 43.374  Millions
Sight Sciences Inc   0.68 $ 78.550  Millions$ 115.807  Millions
Avanos Medical Inc   0.68 $ 714.200  Millions$ 1,057.625  Millions
Strata Critical Medical Inc   0.67 $ 209.937  Millions$ 311.522  Millions
3m Company  0.67 $ 25,024.000  Millions$ 37,192.250  Millions
Anaptysbio Inc   0.67 $ 232.388  Millions$ 345.607  Millions
Establishment Labs Holdings Inc   0.66 $ 228.835  Millions$ 344.192  Millions
Guardant Health Inc   0.66 $ 1,080.215  Millions$ 1,634.434  Millions
U S Physical Therapy Inc  0.66 $ 795.488  Millions$ 1,205.484  Millions
Resmed Inc   0.66 $ 5,504.590  Millions$ 8,360.355  Millions
Urogen Pharma Ltd   0.66 $ 139.526  Millions$ 211.977  Millions
Ani Pharmaceuticals Inc  0.66 $ 923.706  Millions$ 1,403.375  Millions
Dentsply Sirona Inc   0.66 $ 3,681.000  Millions$ 5,595.000  Millions
Pulmonx Corporation  0.66 $ 87.841  Millions$ 133.681  Millions
Align Technology inc   0.66 $ 4,094.492  Millions$ 6,250.128  Millions
Allurion Technologies Inc   0.65 $ 12.357  Millions$ 19.019  Millions
Eli Lilly And Company  0.65 $ 72,249.500  Millions$ 111,227.500  Millions
Tg Therapeutics Inc   0.65 $ 700.349  Millions$ 1,079.932  Millions
Immucell Corporation  0.65 $ 29.035  Millions$ 44.773  Millions
Staar Surgical Co  0.65 $ 290.375  Millions$ 449.235  Millions
Bioaffinity Technologies Inc   0.64 $ 5.660  Millions$ 8.801  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.